Skip to main content
NCBI home page
Mediators of Inflammation logoLink to Mediators of Inflammation
. 2003 Dec;12(6):339–343. doi: 10.1080/09629350310001633379

Evaluation of caspase 1 and sFas serum levels in patients with systemic sclerosis: correlation with lung dysfunction, joint and bone involvement.

Bozena Dziankowska-Bartkowiak 1, Elzbieta Waszczykowska 1, Anna Zalewska 1, Anna Sysa-Jedrzejowska 1
PMCID: PMC1781635  PMID: 14668093

Full Text

The Full Text of this article is available as a PDF (80.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Al-Maini M. H., Mountz J. D., Al-Mohri H. A., El-Ageb E. M., Al-Riyami B. M., Svenson K. L., Zhou T., Richens E. R. Serum levels of soluble Fas correlate with indices of organ damage in systemic lupus erythematosus. Lupus. 2000;9(2):132–139. doi: 10.1191/096120300678828145. [DOI] [PubMed] [Google Scholar]
  2. Bianchi T., Bardazzi F., Patrizi A. Soluble Fas levels in patients with systemic sclerosis. Arch Dermatol Res. 2000 Oct;292(10):522–523. doi: 10.1007/s004030000170. [DOI] [PubMed] [Google Scholar]
  3. Bunn C. C., Black C. M. Systemic sclerosis: an autoantibody mosaic. Clin Exp Immunol. 1999 Aug;117(2):207–208. doi: 10.1046/j.1365-2249.1999.00990.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cohen J. J. Apoptosis. Immunol Today. 1993 Mar;14(3):126–130. doi: 10.1016/0167-5699(93)90214-6. [DOI] [PubMed] [Google Scholar]
  5. Kahaleh M. B., Sultany G. L., Smith E. A., Huffstutter J. E., Loadholt C. B., LeRoy E. C. A modified scleroderma skin scoring method. Clin Exp Rheumatol. 1986 Oct-Dec;4(4):367–369. [PubMed] [Google Scholar]
  6. LeRoy E. C. Increased collagen synthesis by scleroderma skin fibroblasts in vitro: a possible defect in the regulation or activation of the scleroderma fibroblast. J Clin Invest. 1974 Oct;54(4):880–889. doi: 10.1172/JCI107827. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Miwa K., Asano M., Horai R., Iwakura Y., Nagata S., Suda T. Caspase 1-independent IL-1beta release and inflammation induced by the apoptosis inducer Fas ligand. Nat Med. 1998 Nov;4(11):1287–1292. doi: 10.1038/3276. [DOI] [PubMed] [Google Scholar]
  8. Mountz J. D., Wu J., Cheng J., Zhou T. Autoimmune disease. A problem of defective apoptosis. Arthritis Rheum. 1994 Oct;37(10):1415–1420. doi: 10.1002/art.1780371002. [DOI] [PubMed] [Google Scholar]
  9. Nozawa K., Kayagaki N., Tokano Y., Yagita H., Okumura K., Hasimoto H. Soluble Fas (APO-1, CD95) and soluble Fas ligand in rheumatic diseases. Arthritis Rheum. 1997 Jun;40(6):1126–1129. doi: 10.1002/art.1780400617. [DOI] [PubMed] [Google Scholar]
  10. Salvesen G. S., Dixit V. M. Caspases: intracellular signaling by proteolysis. Cell. 1997 Nov 14;91(4):443–446. doi: 10.1016/s0092-8674(00)80430-4. [DOI] [PubMed] [Google Scholar]
  11. Sgonc R., Gruschwitz M. S., Dietrich H., Recheis H., Gershwin M. E., Wick G. Endothelial cell apoptosis is a primary pathogenetic event underlying skin lesions in avian and human scleroderma. J Clin Invest. 1996 Aug 1;98(3):785–792. doi: 10.1172/JCI118851. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Teraki Y., Shiohara T. Apoptosis and the skin. Eur J Dermatol. 1999 Jul-Aug;9(5):413–426. [PubMed] [Google Scholar]
  13. Thornberry N. A., Bull H. G., Calaycay J. R., Chapman K. T., Howard A. D., Kostura M. J., Miller D. K., Molineaux S. M., Weidner J. R., Aunins J. A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes. Nature. 1992 Apr 30;356(6372):768–774. doi: 10.1038/356768a0. [DOI] [PubMed] [Google Scholar]
  14. Tomokuni A., Otsuki T., Isozaki Y., Kita S., Ueki H., Kusaka M., Kishimoto T., Ueki A. Serum levels of soluble Fas ligand in patients with silicosis. Clin Exp Immunol. 1999 Dec;118(3):441–444. doi: 10.1046/j.1365-2249.1999.01083.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Ueki A., Isozaki Y., Tomokuni A., Hatayama T., Ueki H., Kusaka M., Shiwa M., Arikuni H., Takeshita T., Morimoto K. Intramolecular epitope spreading among anti-caspase-8 autoantibodies in patients with silicosis, systemic sclerosis and systemic lupus erythematosus, as well as in healthy individuals. Clin Exp Immunol. 2002 Sep;129(3):556–561. doi: 10.1046/j.1365-2249.2002.01939.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Wang S., Miura M., Jung Y. K., Zhu H., Li E., Yuan J. Murine caspase-11, an ICE-interacting protease, is essential for the activation of ICE. Cell. 1998 Feb 20;92(4):501–509. doi: 10.1016/s0092-8674(00)80943-5. [DOI] [PubMed] [Google Scholar]
  17. Wetzig T., Petri J. B., Mittag M., Haustein U. F. Serum levels of soluble Fas/APO-1 receptor are increased in systemic sclerosis. Arch Dermatol Res. 1998 Apr;290(4):187–190. doi: 10.1007/s004030050288. [DOI] [PubMed] [Google Scholar]
  18. Wyllie A. H. Apoptosis: an overview. Br Med Bull. 1997;53(3):451–465. doi: 10.1093/oxfordjournals.bmb.a011623. [DOI] [PubMed] [Google Scholar]
  19. Wyllie A. H., Kerr J. F., Currie A. R. Cell death: the significance of apoptosis. Int Rev Cytol. 1980;68:251–306. doi: 10.1016/s0074-7696(08)62312-8. [DOI] [PubMed] [Google Scholar]
  20. Zhivotovsky B., Samali A., Gahm A., Orrenius S. Caspases: their intracellular localization and translocation during apoptosis. Cell Death Differ. 1999 Jul;6(7):644–651. doi: 10.1038/sj.cdd.4400536. [DOI] [PubMed] [Google Scholar]

Articles from Mediators of Inflammation are provided here courtesy of Wiley

RESOURCES